Meta Pixel

News and Announcements

Capital Raising 3.0: Unveiling the Future of Venture Investment

  • Published May 31, 2023 11:00PM UTC
  • Publisher Wholesale Investor
  • Categories Capital Insights, Capital Raising Tips

Discover the future of venture investment with Capital Raising 3.0. Join us in this engaging presentation as we delve into the history of capital raising, explore the key focus areas of the innovative Capital Raising 3.0 approach, and highlight how Wholesale Investor leverages its experience in funding companies.

YouTube player

Throughout the years, the landscape of capital raising has evolved, and Capital Raising 3.0 represents the next chapter in this dynamic journey. Gain valuable insights into the changing dynamics and emerging trends that shape the future of venture investment.

Our presentation explores the core principles and strategies of Capital Raising 3.0, providing you with a comprehensive understanding of the key elements that drive success in modern capital raising efforts. We share real-world examples and lessons learned from the companies that Wholesale Investor has supported, offering practical knowledge and actionable advice for entrepreneurs and investors alike.

Don’t miss this opportunity to stay ahead of the curve and navigate the ever-changing world of venture investment. Join us for an informative and thought-provoking session on Capital Raising 3.0 and unlock the potential for growth and success in your capital raising endeavors.

Capital Insights
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer

In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]

Capital Insights
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts

As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.

Join over 45,000+ sophisticated investors

Join Now